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Extra skeletal abnormalitiesAbstract Background: Osteogenesis imperfecta is a genetic disorder of bones, which has different
types. Type III is characterized by recurrent fractures, progressive bone deformities. Cardiac man-
ifestation is one of the important extraskeletal manifestations.
Aim of the study: To asses the ECHO cardiographic findings in Egyptian osteogenesis imperfecta
patients type III (OI III).
Patients and methods: This retrospective study included 35 OI III patients. Their age ranged
from 2 months to 18 years with a mean of 6.34 ± 4.85. Standard echocardiography was performed,
and heart valves were examined. The dimensions of the left ventricle, and ejection fraction were
measured.
Results: Abnormal ECHO findings were found in 8 patients (22.9%). Atrial septal defect (ASD),
and patent ductus arteriosus (PDA) were the commonest cardiac findings with 5.7% each. Trivial
tricuspid regurge was found in 9 patients, this was considered normal finding. There was no signif-
icant difference in ECHO findings between males and females with OI III.
Conclusion and recommendation: The presence of cardiac abnormalities is documented in OI
patients whether congenital or valvular, and so ECHO cardiography should be routine in all
patients with OI.
 2015 Ain Shams University. Production and hosting by Elsevier B.V. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Osteogenesis imperfecta (OI) is a rare genetic disorder charac-
terized by increased risk of fractures with or without trauma.
Other characteristic features include blue sclera, triangular
face, hearing loss more observed in old patients [1].Osteogenesis imperfecta was divided into several types
according to the pattern of inheritance, and phenotype. In
1979, Sillence et al. proposed a phenotypic classification sys-
tem for OI with four types based on severity: type I mild
non-deforming, type II perinatal lethal, type III severely
deforming, and type IV moderately deforming [2]. Another
classification was proposed in 2010 dividing OI into 5 types
depending on clinical and molecular classification [3]. OI is
classified into 11 types to date, on the basis of their clinical
symptoms and genetic components [4].
Table 1 ECHO cardiographic findings in OI III patients.
Frequency Percent
Normal 27 77.1
Abnormal AR dilatation 1 2.9
ASD 2 5.7
MVP 1 2.9
MVP, MR, AVP 1 2.9
PDA 2 5.7
VSD 1 2.9
Total 8 22.9
Total 35 100.0
ASD: atrial septal defect, PDA: patent ductus arteriosus, AR:
aortic root, MVP: mitral valve prolapse, MR: mitral regurge, AVP:
aortic valve prolapse, VSD: ventricular septal defect.
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mutations in the COL1A1 and COL1A2 genes. Mutations in
several different genes also were identified as a cause of OI
including CRTAP, FKBP10, LEPRE1, PLOD2, PPIB, SER-
PINF1, SERPINH1, SP7, WNT1, BMP1, TMEM38B,
IFITM5 gene, and PLS3 genes [5]. Decreased synthesis of nor-
mal collagen to 50% due to one null allele of COL1A1 gene
mutations results in mild type I OI while mutations of procol-
lagen chains genes have more deleterious phenotypic conse-
quences (types II, III and IV OI) [6].
Several extraskeletal manifestations are present including
cardiac, renal, dental, and ocular manifestations [7]. A limited
number of studies have been conducted on the children with
OI to assess the prevalence of cardiovascular abnormalities [8].
The non-skeletal manifestations of OI in the respiratory
and cardiovascular systems are the main cause of mortality
and morbidity in OI which may be due to skeletal changes [9].
Cardiovascular findings which had been reported previ-
ously include valvular (aortic, and mitral) insufficiency, aortic
root dilation, atrial septal defects and septal and posterior left
ventricular wall thickening, and impairment of diastolic func-
tion [7,10–15].
2. Subjects and methods
This retrospective study included 35 infants and children diag-
nosed with osteogenesis imperfecta type III (OI III) according
to Sillence classification [2]. The patients were following up at
the Genetics Unit, Children’s Hospital, Faculty of Medicine,
Ain Shams University, Cairo, Egypt. By revising the data
recorded in the files, detailed full history with special emphasis
on age, sex, symptoms of cardiac affection was reviewed.
A standard two-dimensional, M-mode, color flow, continu-
ous wave and pulsed wave (PW) Doppler echocardiography
examinations were performed for all patients using the seg-
mental sequential approach.
2.1. Statistical methodology
Analysis of data was performed using standard computer pro-
gram statistical package for social sciences (SPSS) 15 for win-
dows (SPSS Incorporation, USA). P< 0.05 was considered
significant.
3. Results
This study included 35 OI III infants and children, they were
18 males (51.4%) and 17 females (48.6%). Their age ranged
from 2 months to 18 years with a mean of 6.34 ± 4.85. Paren-
tal consanguinity was positive in 65.6% of patients.
ECHOcardiography results showed that 27 patients (77.1%)
had normal cardiac function, and 8 patients (22.9%) had abnor-
mal ECHO findings (Table 1). Atrial septal defect (ASD), and
patent ductus arteriosus (PDA) were the commonest cardiac
findings with 5.7% each. Trivial tricuspid regurge (TR) was
found in 9 patients but it was considered normal finding.
Estimations of ventricular dimensions, and ejection fraction
were done (Table 2).
Cardiac murmur was evident during examination in (5/35)
14.3% of patients, those patients had ASD, ventricular septal
defect (VSD), or PDA which were confirmed by ECHO, whilepatients with valvular affection were detected by ECHO only
with no cardiac murmurs or clinical manifestations.
A female patient who had ASD was maintained on treat-
ment for control of heart failure in the form of lasix and
lanoxin. Later the patient died of cardiac complications at
the age of 3 years. The cardiac condition in the other patients
with abnormal findings was stable and did not necessitate
specific treatment.
There was no significant difference in ECHO findings
between males and females with OI III as shown in Table 3.
4. Discussion
OI preferentially affects the left-sided heart valves, leading to
aortic and mitral regurgitation. The valvular insufficiency in
patients with osteogenesis imperfecta results from an underlying
defect in connective tissue formation [8], however aortic root
dilation is the most common cardiovascular manifestation [15].
In this study, abnormal ECHO findings were detected in
22.9% (8/35) of patients with OI III, from which 14.3%
(5/35) were congenital heart disease. This finding was higher
than what was reported in a previous study done by Veter
who reported congenital heart disease in 6.9% (4/58) of
patients with osteogenesis imperfecta of any type, and 8%
(2/25) OI III patients had congenital heart disease [7].
The prevalence of congenital heart in this study is much
higher than that in normal population which differs greatly
from study to study, it ranged from 4/1,000 to 50/1,000 live
births [16].
In this study ASD, PDA were the commonest congenital
heart diseases detected followedbyVSD.ASDwas reportedpre-
viously in OI III patients, also other types of congenital heart
were also reported in different types of OI including Fallot
tetralogy, congenital aortic stenosis, also increased septal
(40%) and posterior left ventricular wall thickening (68%) [7].
In this study there was valvular affection in 8.6% (3/35) of
patients, which represents 37.5% of the abnormal cardiac find-
ings in OI III patients. Of which mitral regurge (MR), mitral
valve prolapse (MVP), and dilated aortic root were docu-
mented once each. Valvular dysfunction was previously
detected in 3.7% (4/109) of patients (aortic regurgitation in
two, aortic stenosis, mitral valve prolapse in one each) [10].
Both studies’ results were comparable.
Table 2 Estimation of different cardiac functions.
LVEDD LVPWTD LVESD IVSD LAD AR ACS EF PP FS
Mean 33.14 4.83 18.80 10.00 27.33 19.25 13.00 68.43 24.25 51.00
Median 35.00 4.80 20.00 5.00 25.50 19.00 13.00 69.00 24.00 47.00
SD 4.981 .898 2.683 8.266 15.946 1.258 .816 8.203 2.217 14.422
Range 14 2 6 19 48 3 2 21 5 28
Minimum 23 4 15 4 6 18 12 59 22 39
Maximum 37 6 21 23 54 21 14 80 27 67
LVEDD: left ventricular end diastolic diameter, LVPWTD: left ventricular posterior wall thickness in diastole, LVESD: left ventricular end
systolic diameter, IVSD: interventricular septum in diastole, LAD: left atrial diameter, AR: aortic root, EF: ejection fraction, PP: pulmonary
pressure, FS: fractional shortening.
Table 3 Correlation between sex of the patient and ECHO findings.
ECHO AR dilatation ASD MVP MVP, MR, AVP Normal PDA VSD Total P
Sex Female 0 2 1 1 11 1 1 17 0.33
Male 1 0 0 0 16 1 0 18
Total 1 2 1 1 27 2 1 35
ASD: atrial septal defect, PDA: patent ductus arteriosus, AR: aortic root, MVP: mitral valve prolapse, MR: mitral regurge, AVP: aortic valve
prolapse, VSD: ventricular septal defect.
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patients. The percent of aortic root dilatation was different
in different studies; it ranged between 12.1% [10] and 28%
[7]. The variation in the percentage of affection between differ-
ent studies may be related to age difference, being higher in
Veter et al., study [7]. Also its extent was mild nonprogressive
and may be not related to age, and it was segregated within
certain families [10].
Mitral valve prolapse represents (2/35) 5.7% either alone
(1/35) or associated with mitral regurge (1/35). It was reported
in Hortop et al., study to be 6.9% which was similar to adult
population [10].
Patients with OI III had right ventricular (RV) dimensions
and pulmonary artery (PA) which were significantly larger
compared to patients with OI I, IV and controls [17]. In this
study RV and PA dimensions were within the normal range.
Also, the study results revealed no significant difference
between cardiac abnormalities and the patients’ sex, which is
the same finding reported by Karamifar et al. [8].
Parental consanguinity was present in 65.6% of the patients
which is high and cannot be explained by the high consanguin-
ity rate in Egypt [18]. But it supports the findings that OI III is
mostly an autosomal recessive disease.
5. Conclusion and recommendations
The presence of cardiac abnormalities is documented in OI
patients whether congenital or valvular and it needs further
studies to detect if it is related to specific type or genetic
abnormalities.
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